Korro Bio (KRRO) Other Working Capital Changes (2018 - 2026)
Korro Bio's (KRRO) quarterly Other Working Capital Changes came in at -$9.4 million in Q2 2021, down 10.49% YoY from -$10.5 million in Q2 2020, and down 102.47% on a QoQ basis from -$4.7 million in Q1 2021.
Korro Bio (KRRO) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has 3 years of Other Working Capital Changes data on file, last reported at -$9.4 million in Q2 2021.
- Quarterly Other Working Capital Changes fell 10.49% year-over-year to -$9.4 million in Q2 2021, while the trailing twelve-month figure through Mar 2022 was -$9.4 million (up 72.6% YoY) and the FY2021 annual result came in at -$14.1 million, up 61.96% from the prior year.
- Other Working Capital Changes fell to -$9.4 million in Q2 2021, from -$4.7 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $9.7 million in Q4 2024 to a low of -$1.8 million in Q4 2025.
- A 5-year average of $454764.7 and a median of -$58000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes slumped 111.25% — and 2021, when it soared 35.97%.
- Tracing KRRO's Other Working Capital Changes over 3 years: stood at -$4.7 million in 2019, then plunged by 111.25% to -$10.0 million in 2020, then increased by 5.36% to -$9.4 million in 2021.
- The last three Other Working Capital Changes figures came in at -$9.4 million (Q2 2021), -$4.7 million (Q1 2021), and -$10.0 million (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Korro Bio | 233.09 Mn | 118.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 477,000.00 |
| Jun 30, 2026 | 477,000.00 |
| Jun 30, 2026 | 477,000.00 |
| Mar 31, 2026 | -132,000.00 |
| Mar 31, 2026 | -132,000.00 |
| Mar 31, 2026 | -132,000.00 |
| Dec 31, 2025 | -1.78 Mn |
| Dec 31, 2025 | -1.78 Mn |
| Dec 31, 2025 | -1.78 Mn |
| Sep 30, 2025 | -256,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Sep 30, 2025 | -256,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Mar 31, 2025 | 406,000.00 |
| Dec 31, 2024 | 9.66 Mn |
| Dec 31, 2024 | 9.66 Mn |